应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02359 药明康德
已收盘 01-14 16:08:06
118.700
-1.300
-1.08%
最高
122.200
最低
117.000
成交量
801.06万
今开
119.300
昨收
120.000
日振幅
4.33%
总市值
3,542亿
流通市值
605.94亿
总股本
29.84亿
成交额
9.53亿
换手率
1.57%
流通股本
5.10亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
花旗:将药明康德(02359)列入90日上行催化剂观察 目标价142港元
智通财经 · 14:26
花旗:将药明康德(02359)列入90日上行催化剂观察 目标价142港元
里昂:药明康德(02359)为中国医药CRO或CDMO行业首选 料今年可跑赢同业
智通财经 · 14:20
里昂:药明康德(02359)为中国医药CRO或CDMO行业首选 料今年可跑赢同业
【券商聚焦】越秀证券指恒指连升三日创两月高,金价再创新高
金吾财讯 · 11:56
【券商聚焦】越秀证券指恒指连升三日创两月高,金价再创新高
小摩:药明康德(02359)盈喜胜预期 料市场将有正面反应
智通财经 · 10:10
小摩:药明康德(02359)盈喜胜预期 料市场将有正面反应
智通港股解盘 | 担忧地缘政治多数黄金股创历史新高 利好推动CXO全线走强
智通财经 · 01-13 20:42
智通港股解盘 | 担忧地缘政治多数黄金股创历史新高 利好推动CXO全线走强
创新药板块强势上涨 多股获融资客加仓
DoNews · 01-13 18:53
创新药板块强势上涨 多股获融资客加仓
每日卖空追踪 | 药明康德 01月13日卖空量成交98.22万股,卖空比例为8.49%
市场透视 · 01-13 16:30
每日卖空追踪 | 药明康德 01月13日卖空量成交98.22万股,卖空比例为8.49%
药明康德涨6.00%,浦银国际证券二个月前给出“买入”评级,目标价124.40元
证券之星 · 01-13 15:33
药明康德涨6.00%,浦银国际证券二个月前给出“买入”评级,目标价124.40元
BD大单扎堆、龙头业绩预增翻倍,港A创新药掀起暴涨浪潮
格隆汇 · 01-13 15:25
BD大单扎堆、龙头业绩预增翻倍,港A创新药掀起暴涨浪潮
港股异动 | CRO概念股涨幅居前 药明康德(02359)去年净利预计翻倍 板块有望迎“戴维斯双击”
智通财经 · 01-13 10:09
港股异动 | CRO概念股涨幅居前 药明康德(02359)去年净利预计翻倍 板块有望迎“戴维斯双击”
商业航天大面积跌停,AI应用继续大涨
大河财立方 · 01-13 10:06
商业航天大面积跌停,AI应用继续大涨
港股医药股走强 药明康德涨超7%
每日经济新闻 · 01-13 09:56
港股医药股走强 药明康德涨超7%
港股创新药概念股盘初普涨!乐普生物-B涨超8%,药明康德涨超7%
老虎资讯综合 · 01-13 09:45
港股创新药概念股盘初普涨!乐普生物-B涨超8%,药明康德涨超7%
药明康德预计2025年归母净利同比增长约102.65%
老虎资讯综合 · 01-13 09:40
药明康德预计2025年归母净利同比增长约102.65%
药明康德预计年度净利同比增长102.65%;医疗反腐持续加码
21世纪经济报道 · 01-13 08:32
药明康德预计年度净利同比增长102.65%;医疗反腐持续加码
港股公告掘金 | 药明康德预计2025年归母净利润约191.51亿元 同比增长约102.65%
智通财经 · 01-12 22:55
港股公告掘金 | 药明康德预计2025年归母净利润约191.51亿元 同比增长约102.65%
【财闻联播】6个交易日涨199%!这家公司明起停牌核查!药明康德2025年净利同比预增近103%
券商中国 · 01-12 20:57
【财闻联播】6个交易日涨199%!这家公司明起停牌核查!药明康德2025年净利同比预增近103%
美股三大指数齐升 恒指50天线料有不俗支援
真灼财经 · 01-12 20:45
美股三大指数齐升 恒指50天线料有不俗支援
当业绩创纪录新高:药明康德为股东与员工备好“双份礼包“”——有望创新高的分红与25亿元H股激励即将解锁
时代周报 · 01-12 19:33
当业绩创纪录新高:药明康德为股东与员工备好“双份礼包“”——有望创新高的分红与25亿元H股激励即将解锁
完全拦不住,又双叒超指引了,药明康德(603259.SH/02359)2025年营收创记录至454.56亿元
智通财经 · 01-12 18:35
完全拦不住,又双叒超指引了,药明康德(603259.SH/02359)2025年营收创记录至454.56亿元
加载更多
公司概况
公司名称:
药明康德
所属市场:
SEHK
上市日期:
--
主营业务:
无锡药明康德新药开发股份有限公司是一家主要从事新药研发和生产服务业务的中国公司。该公司主要通过六个分部开展业务。化学业务分部主要从事提供新药研究、开发与生产服务。测试业务分部主要从事提供药品、医疗器械、体外诊断试剂服务。生物学业务分部主要从事提供药物发现及研究服务。高端治疗合同测试、研发与生产(CTDMO)业务分部主要从事为客户提供医疗产品工艺开发、生产和测试一体化服务。国内新药研发服务部分部主要从事为客户提供一体化新药研发服务。其他业务分部主要从事行政服务、销售原材料和销售废料业务。
发行价格:
--
{"stockData":{"symbol":"02359","market":"HK","secType":"STK","nameCN":"药明康德","latestPrice":118.7,"timestamp":1768378086004,"preClose":120,"halted":0,"volume":8010591,"delay":0,"changeRate":-0.01083333333333331,"floatShares":510476909,"shares":2984000000,"eps":3.0675401961313264,"marketStatus":"已收盘","change":-1.3,"latestTime":"01-14 16:08:06","open":119.3,"high":122.2,"low":117,"amount":953476388,"amplitude":0.043333,"askPrice":118.8,"askSize":5600,"bidPrice":118.7,"bidSize":10500,"shortable":3,"etf":0,"ttmEps":5.205270530075394,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768440600000},"marketStatusCode":5,"adr":0,"listingDate":1544630400000,"exchange":"SEHK","adjPreClose":120,"dividendRate":0.01253,"openAndCloseTimeList":[[1768354200000,1768363200000],[1768366800000,1768377600000]],"volumeRatio":0.990709,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"603259","market":"SH","secType":"STK","nameCN":"药明康德","latestPrice":103.4,"timestamp":1768374000000,"preClose":104.6,"halted":0,"volume":63223900,"delay":0,"premium":"+2.65"}},"requestUrl":"/m/hq/s/02359","defaultTab":"news","newsList":[{"id":"2603281662","title":"花旗:将药明康德(02359)列入90日上行催化剂观察 目标价142港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603281662","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603281662?lang=zh_cn&edition=full","pubTime":"2026-01-14 14:26","pubTimestamp":1768371992,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,花旗发布研报称,对药明康德(02359)列入90日上行催化剂观察,又指集团将于太平洋时间周三(14日)参加美国一场医疗保健会议并发表演讲。基于全球融资复苏,花旗预计药明康德管理层对今年前景保持乐观,并在3月业绩财报上会给出更清晰的2026年业绩指引及细节。药明康德估值吸引,予其“买入”评级,目标价142港元。该行预计,药明康德强劲的增长前景,将得到来自国内外不断增加的订单量支持,预计得益于其“长尾”策略和创新平台提供差异化服务的支持,中国实验室业务在2020至2023年的销售复合年均增长率达27.4%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1392666.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02359","603259"],"gpt_icon":0},{"id":"2603664448","title":"里昂:药明康德(02359)为中国医药CRO或CDMO行业首选 料今年可跑赢同业","url":"https://stock-news.laohu8.com/highlight/detail?id=2603664448","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603664448?lang=zh_cn&edition=full","pubTime":"2026-01-14 14:20","pubTimestamp":1768371626,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,里昂发布研报称,展望2026年,相信对中国医疗板块而言,盈利交付将比估值扩张更为重要,料药明康德 有望跑赢同业。该行将药明康德列为中国CRO/CDMO行业的首选。该行维持药明康德“跑赢大市”评级及目标价143.4港元。相较同行,药明康德具备更强的盈利增长可见性:其2025年前三季度订单储备同比增长41%,远高于全球平均约14%,即使在地缘政治风险持续的背景下仍保持强劲增势。该行预计2026年药明康德的订单增速将继续领先全球同行。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1392662.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0185","LU0052750758.USD","LU0708995583.HKD","LU0320764599.SGD","603259","LU1997244956.HKD","LU2242644610.SGD","BK0175","BK1141","CDMO","LU2488822045.USD","BK0082","BK0216","LU1046422090.SGD","02359","BK0010","LU2495084118.USD","BK1583","BK1576","600056","LU1808992512.USD","BK0250","BK0188","LU1997245094.SGD","LU2045819591.USD","BK0028","LU1934453819.USD","LU2125910500.SGD","BK4139","LU1979443071.USD","LU1997245177.USD","LU1969619763.USD","LU0456842615.SGD","LU2328871848.SGD"],"gpt_icon":0},{"id":"2603664476","title":"【券商聚焦】越秀证券指恒指连升三日创两月高,金价再创新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2603664476","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603664476?lang=zh_cn&edition=full","pubTime":"2026-01-14 11:56","pubTimestamp":1768363016,"startTime":"0","endTime":"0","summary":"金吾财讯|越秀证券发布研报指,前一交易日恒生指数收涨0.9%至26,848点,连升3日创两个月新高,主板成交额达3,152亿港元创两个半月高位。国际金价创新高带动紫金矿业升5%。美国12月CPI同比维持2.7%符合预期,核心CPI同比2.6%低于预期。中国将对美韩进口太阳能级多晶硅续征反倾销税五年。工信部强调要稳定制造业投资,自觉抵制行业\"内卷\"。全球市场方面,道指跌0.8%,标普500跌0.19%,纳指微跌0.1%。欧洲三大股指基本持平。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114122957a4c1895e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114122957a4c1895e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HSTECH","BK4614","HSI","603259","02359","601899"],"gpt_icon":1},{"id":"2603668859","title":"小摩:药明康德(02359)盈喜胜预期 料市场将有正面反应","url":"https://stock-news.laohu8.com/highlight/detail?id=2603668859","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603668859?lang=zh_cn&edition=full","pubTime":"2026-01-14 10:10","pubTimestamp":1768356602,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,摩根大通发布研报称,药明康德(02359)经调整净利率扩张至33%亦是另一个正面惊喜; 现予目标价142港元及“增持”评级。药明康德日前发盈喜,料2025年销售同比升16%至455亿元人民币(下同),胜该行预期2%; 经调整净利润预计同比升41%至150亿元,较该行预期高4%。该行认为,表现胜预期主要由持续的能力与产能提升、生产流程优化,以及营运效率改善所推动; 料市场对盈喜将有正面反应。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1392568.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2125910500.SGD","LU2237443382.USD","LU0265550946.USD","LU1894683348.USD","LU1988902786.USD","LU0251132253.USD","LU1363072403.SGD","LU0820562030.AUD","LU0203347892.USD","IE00B1XK9C88.USD","LU0267386448.USD","LU2213496289.HKD","LU1720051017.SGD","LU0170899867.USD","LU2430703251.USD","LU2357305700.SGD","LU0345769128.USD","LU1551013342.USD","LU0971096721.USD","LU0203345920.USD","LU1670627923.USD","LU0211331839.USD","LU2552382058.USD","BK1141","LU1974910355.USD","LU2488822045.USD","LU1551013425.SGD","LU2211815571.USD","02359","LU1119994496.HKD","LU1162221912.USD","LU1894683264.USD","LU2430703095.HKD","IE00BJLML261.HKD","LU1244550494.USD","IE00BYXW3230.USD","LU1997245094.SGD","603259","LU0320765489.SGD","LU0238689110.USD","IE00BHPRN162.USD","LU1064131342.USD","IE00B1BXHZ80.USD","LU0345770308.USD","LU1280957306.USD","LU2552382132.HKD","LU0211328371.USD","BK4533","LU2462157665.USD","BK4581"],"gpt_icon":0},{"id":"2603681308","title":"智通港股解盘 | 担忧地缘政治多数黄金股创历史新高 利好推动CXO全线走强","url":"https://stock-news.laohu8.com/highlight/detail?id=2603681308","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603681308?lang=zh_cn&edition=full","pubTime":"2026-01-13 20:42","pubTimestamp":1768308157,"startTime":"0","endTime":"0","summary":"恒指不敢持续发力,因为还是有担忧情绪,当地时间12日,美国国务院在网站上发布信息,要求美国公民立即离开伊朗。智通1月金股——紫金黄金国际也涨超5%,同样创出了上市以来的新高。中方将坚定维护自身正当合法权益。这对中国创新药企是好消息。近日,研究服务业务首付款和总付款金额再创新高,去年合作项目的潜在里程碑付款总额高达40亿美元以上。紫金矿业巨龙铜矿项目二期全面达产后,将新增日处理20万吨矿石的产能。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1392385.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1117","LU0052750758.USD","LU2213484517.USD","BK1141","HK0000252160.HKD","SGXZ62798434.SGD","LU2045819591.USD","BK1522","02359","LU2543165471.USD","LU1046422090.SGD","HK0000252152.HKD","BK1583","BK1198","BK1161","01072","LU2125910500.SGD","BK1576","LU0593848301.USD","HK0000500386.USD","02259","BK1546","LU0708995583.HKD","159562","LU0320764599.SGD","CXO","BK1205","LU2242644610.SGD","02315","SGXZ86797644.SGD"],"gpt_icon":1},{"id":"2603689390","title":"创新药板块强势上涨 多股获融资客加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2603689390","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603689390?lang=zh_cn&edition=full","pubTime":"2026-01-13 18:53","pubTimestamp":1768301583,"startTime":"0","endTime":"0","summary":"自去年12月17日以来,创新药板块指数上涨近10%,期间杠杆资金集中买入多只个股。2026年开年以来,恒瑞医药的瑞拉芙普α注射液、泽璟制药的注射用人促甲状腺素β、百济神州的索托克拉片等多款新药相继获批上市,另有多个国产创新药新适应症或临床试验申请获国家药监局批准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113185819a7158683&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113185819a7158683&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1046422090.SGD","LU2242644610.SGD","06978","LU0320764599.SGD","BK1583","BK1141","BK1574","02359","BK1161","LU0052750758.USD","BK1576","LU2125910500.SGD","LU0708995583.HKD","LU2045819591.USD"],"gpt_icon":0},{"id":"2603689332","title":"每日卖空追踪 | 药明康德 01月13日卖空量成交98.22万股,卖空比例为8.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603689332","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603689332?lang=zh_cn&edition=full","pubTime":"2026-01-13 16:30","pubTimestamp":1768293029,"startTime":"0","endTime":"0","summary":"药明康德北京时间01月13日,涨8.3%,卖空量成交98.22万股,较上一交易日增加59.19%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113165318a4be1229&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113165318a4be1229&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2045819591.USD","LU0320764599.SGD","BK1141","LU2125910500.SGD","LU2242644610.SGD","BK1576","LU0708995583.HKD","02359","BK1583","LU1046422090.SGD","LU0052750758.USD"],"gpt_icon":0},{"id":"2603505369","title":"药明康德涨6.00%,浦银国际证券二个月前给出“买入”评级,目标价124.40元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603505369","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603505369?lang=zh_cn&edition=full","pubTime":"2026-01-13 15:33","pubTimestamp":1768289637,"startTime":"0","endTime":"0","summary":"今日药明康德涨6.00%,收盘报104.6元。2025年10月28日,浦银国际证券研究员阳景,胡泽宇发布了对药明康德的研报《3Q25业绩及新签订单增速再超预期,上调全年指引》,该研报对药明康德给出“买入”评级,认为其目标价为124.4元,现价距离目标价尚有18.93%的涨幅空间。证券之星数据中心根据近三年发布的研报数据计算,该研报作者对此股的盈利预测准确度为79.37%。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为民生证券的乔波耀。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300020376.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["02359","161027","603259"],"gpt_icon":0},{"id":"1135640998","title":"BD大单扎堆、龙头业绩预增翻倍,港A创新药掀起暴涨浪潮","url":"https://stock-news.laohu8.com/highlight/detail?id=1135640998","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135640998?lang=zh_cn&edition=full","pubTime":"2026-01-13 15:25","pubTimestamp":1768289121,"startTime":"0","endTime":"0","summary":"BD合作密集披露近期,被誉为“医药春晚”的行业盛会顺利召开,进一步点燃了医药板块的市场热度。1月12日,药明康德发布2025年度业绩预告,多项核心指标实现强劲增长。1月7日,恒瑞医药公告称,1类创新药瑞拉芙普α注射液获批上市国内外尚无同类产品获批上市。华泰证券表示,自10月以来,BD出海交易共计发生49单,总金额超过390亿美元。有部分市场预期较高的BD虽然有时间上的推迟,但交易持续进展,创新药出海趋势一如既往。","market":"hk","thumbnail":"https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/3569925","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["02359","09995","02269"],"gpt_icon":0},{"id":"2603575538","title":"港股异动 | CRO概念股涨幅居前 药明康德(02359)去年净利预计翻倍 板块有望迎“戴维斯双击”","url":"https://stock-news.laohu8.com/highlight/detail?id=2603575538","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603575538?lang=zh_cn&edition=full","pubTime":"2026-01-13 10:09","pubTimestamp":1768270178,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,CRO概念股涨幅居前,截至发稿,药明康德涨8.48%,报120.2港元;凯莱英涨7.4%,报91.4港元;康龙化成涨7.13%,报24.64港元;泰格医药涨7.16%,报53港元;药明生物涨5%,报39.46港元。消息面上,1月12日晚,药明康德公布,公司全年预计实现营业收入454.56亿元,同比增长15.84%;其中,持续经营业务收入同比增长约21.40%。预计经调整归母净利润149.57亿元,同比增长约41.33%;归属于公司股东的净利润191.51亿元,同比增长约 102.65%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1392032.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603259","LU0572944931.SGD","LU0819121731.USD","LU0456842615.SGD","LU1242518857.USD","03347","02359","LU0456827905.SGD","LU2495084118.USD","LU1997245094.SGD","SG9999002562.SGD","LU0588546209.SGD","LU2125910500.SGD","LU0516423091.SGD","LU0417516738.SGD","LU0039217434.USD","BK0216","LU1046422090.SGD","LU0856984785.SGD","LU1720050803.USD","LU0140636845.USD","LU0359201612.USD","LU1794554557.SGD","LU1808992512.USD","BK1610","LU2045819591.USD","SG9999002463.SGD","IE00B0JY6N72.USD","LU1997244956.HKD","BK1141","LU0181495838.USD","03759","LU0051755006.USD","LU0456846285.SGD","BK1583","LU0516422440.USD","LU3063872942.SGD","06821","LU0320764599.SGD","LU0052750758.USD","LU0708995583.HKD","LU0516422366.SGD","LU2039709279.SGD","LU0348825331.USD","LU0417516902.SGD","02269","LU1934453819.USD","LU0823426308.USD","LU1997245177.USD","BK1576"],"gpt_icon":0},{"id":"2603575987","title":"商业航天大面积跌停,AI应用继续大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2603575987","media":"大河财立方","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603575987?lang=zh_cn&edition=full","pubTime":"2026-01-13 10:06","pubTimestamp":1768270010,"startTime":"0","endTime":"0","summary":"大河财立方记者 夏晨翔 任浩鹏1月13日开盘,A股三大指数集体高开后震荡,医疗、CRO、生物科技、AI应用、文化传媒、虚拟人、AIGC、保险等概念涨幅居前;商业航天、卫星导航、低空经济、卫星互联网等概念跌幅居前。12日晚间,多个热门赛道概念股发布异常波动、风险提示、停牌核查公告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011310120797a189a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011310120797a189a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1610","LU0634319403.HKD","LU1023057109.AUD","LU2097828805.USD","LU2449936058.SGD","SG9999006597.SGD","300063","BK1540","LU0143863784.USD","LU0259732245.USD","LU0708995583.HKD","LU0509642566.USD","LU0348825331.USD","LU0823039010.USD","LU0871576103.HKD","LU0359202008.SGD","LU0561508036.HKD","LU0164872284.USD","LU0516423091.SGD","SG9999015952.SGD","BK1522","LU0084288322.USD","LU0254981946.USD","LU0359201612.USD","03986","BK1539","LU1808992512.USD","LU0315178854.USD","LU2476274720.SGD","LU1720050803.USD","603598","LU2506951792.HKD","LU0650527681.SGD","LU1880383440.USD","LU2097828474.EUR","LU0348827113.USD","LU0214875030.USD","LU0543330566.HKD","LU0979878070.USD","LU0856984785.SGD","LU2294711713.HKD","LU2153592121.USD","LU0054450605.USD","LU0823414551.USD","LU1242518857.USD","002594","LU0417516902.SGD","LU0314109678.HKD","LU0175139822.USD","LU0588546209.SGD","LU0823038988.USD","81211","LU0327786744.USD","LU0449515922.USD","LU0320764599.SGD","LU0588545904.SGD","LU0605514214.HKD","LU2476274308.USD","LU1868837722.USD","300785","LU0594300419.USD","LU2039709279.SGD","600880","LU0269904917.USD","SG9999014674.SGD","02359","600151","LU1251922891.USD","00241","LU1303224171.USD","LU1961090484.USD","LU2097828631.EUR","LU0531971595.HKD","HYDD.SI","301230","LU1861214812.USD","002149","LU0289961442.SGD","LU0307460666.USD","LU0348805143.USD","LU0229945570.USD","LU0039217434.USD","LU0516422440.USD","LU0417516738.SGD","LU1242518931.SGD","601698","LU2357125470.USD","BK1509","LU0823426480.USD","LU0289960550.SGD","688331","BYDDY","LU0165289439.USD","LU1868838027.USD","LU0819121731.USD","LU1770034418.SGD","LU2249611893.SGD","LU0540923850.HKD","BK1594","SG9999015945.SGD","SG9999002463.SGD","LU0516422952.EUR","300244","600986","LU0594300179.USD","LU1794554557.SGD","LU0289739343.SGD","LU0505663152.USD","LU0516422366.SGD","603259","LU0359201885.HKD","LU0164865239.USD","LU0823414478.USD","01211","000547","SG9999006514.SGD","LU0572944931.SGD","LU2360107325.USD","LU2399975544.HKD","LU0593848301.USD","09868","LU1868837565.USD","LU1861219969.SGD","BK1119","LU0819123356.HKD","LU0588545490.SGD","09995","LU0348735423.USD","IE00BD6J9T35.USD","LU0531970944.HKD","LU0043850808.USD","LU0211977185.USD","301171","09988","SG9999001226.SGD","LU0865486749.SGD","SG9999015978.USD","BK1582","LU0052750758.USD","LU0463099449.HKD","LU0588545730.USD","LU0516423174.USD","002413","LU0511384066.AUD","LU0449509016.USD","LU0469268626.HKD","LU0326950275.SGD","LU0828238088.HKD","603986","LU2348774022.SGD","SG9999015986.USD","SG9999002828.SGD","LU0244354667.USD","LU0823426308.USD","LU1719994722.HKD","LU1328277881.USD","LU2097828714.EUR","LU1188198961.HKD","LU2778985437.USD","LU1813983027.USD","002131","LU2097828557.USD","LU1880383366.USD","002044","LU0143863198.USD"],"gpt_icon":1},{"id":"2603575337","title":"港股医药股走强 药明康德涨超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603575337","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603575337?lang=zh_cn&edition=full","pubTime":"2026-01-13 09:56","pubTimestamp":1768269411,"startTime":"0","endTime":"0","summary":"每经AI快讯,1月13日,港股医药股走强。截至发稿,荣昌生物(09995.HK)涨9.38%、基石药业-B(02616.HK)涨6.66%、药明康德(02359.HK)涨6.32%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601133616873377.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"d9a285c5d35960016c392e2c485f56f0","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601133616873377.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1046422090.SGD","LU1997245094.SGD","603259","LU2045819591.USD","LU0456842615.SGD","BK1141","BK1583","BK1576","LU2125910500.SGD","LU0708995583.HKD","LU2488822045.USD","LU1979443071.USD","LU1934453819.USD","LU0320764599.SGD","LU1969619763.USD","02359","LU2495084118.USD","LU1997244956.HKD","LU0052750758.USD","LU1997245177.USD","LU2242644610.SGD","LU2328871848.SGD","159718","BK0216","LU1808992512.USD"],"gpt_icon":0},{"id":"1137978914","title":"港股创新药概念股盘初普涨!乐普生物-B涨超8%,药明康德涨超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1137978914","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137978914?lang=zh_cn&edition=full","pubTime":"2026-01-13 09:45","pubTimestamp":1768268737,"startTime":"0","endTime":"0","summary":"1月13日,港股创新药概念股盘初普涨,$乐普生物-B(02157)$涨超8%,$药明康德(02359)$涨超7%,$三生制药(01530)$、$晶泰控股(02228)$涨超6%,$歌礼制药-B(01672)$涨超4%,$复星医药(02196)$、$云顶新耀(01952)$涨超3%。","market":"hk","thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"d9a285c5d35960016c392e2c485f56f0","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","BK1161","01530","01672","02228","02359","LU2045819591.USD","BK1617","LU2125910500.SGD","01952","HK0000165453.HKD","02157","BK1515","02196","LU0320764599.SGD","BK1141","BK1593","BK1574","LU0052750758.USD","LU2242644610.SGD","BK1576","BK1583","LU1046422090.SGD","01477","LU0708995583.HKD"],"gpt_icon":0},{"id":"1159594909","title":"药明康德预计2025年归母净利同比增长约102.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=1159594909","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159594909?lang=zh_cn&edition=full","pubTime":"2026-01-13 09:40","pubTimestamp":1768268413,"startTime":"0","endTime":"0","summary":"1月13日,药明康德涨超6%!公司预计2025年归母净利同比增长约102.65%。1月12日,药明康德发布公告,预期本公司(连同其子公司统称为:本集团)于截至2025年12月31日止年度(本期)营业收入及归属于本公司股东的净利润相比2024年年度同期(上年同期)将取得上升。公司预计本期实现归属于本公司股东的净利润约人民币191.51亿元,同比增长约102.65%,其中包含了出售联营公司部分股权以及剥离部分业务所获得的投资收益;本期基本每股收益预计约人民币6.70元╱股,同比增长约104.27%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["603259","02359"],"gpt_icon":0},{"id":"2603359520","title":"药明康德预计年度净利同比增长102.65%;医疗反腐持续加码","url":"https://stock-news.laohu8.com/highlight/detail?id=2603359520","media":"21世纪经济报道","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603359520?lang=zh_cn&edition=full","pubTime":"2026-01-13 08:32","pubTimestamp":1768264330,"startTime":"0","endTime":"0","summary":"政策动向医疗反腐持续加码2026年1月12日,国家医保局官微发布《党某海犯非国家工作人员受贿罪案》显示,2012年至2023年期间,被告人党某海在担任双丰林业局职工医院内科医生期间,利用开具处方的职务便利,收受多家医药公司业务员和销售经理给予的药品回扣款,共计78.91万元。医药行业因资金链条长、权力集中度高、利润空间较大,历来是腐败风险高发领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601133616461947.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"d9a285c5d35960016c392e2c485f56f0","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601133616461947.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1997245177.USD","02359","LU2045819591.USD","603259","LU2495084118.USD","LU2125910500.SGD","LU2488822045.USD","LU1934453819.USD","LU0456842615.SGD","LU1997245094.SGD","LU1969619763.USD","159891","LU0320764599.SGD","BK1141","LU0052750758.USD","LU1808992512.USD","LU2242644610.SGD","BK1576","LU1997244956.HKD","BK1583","BK0216","LU1979443071.USD","LU1046422090.SGD","LU2328871848.SGD","LU0708995583.HKD"],"gpt_icon":0},{"id":"2602554921","title":"港股公告掘金 | 药明康德预计2025年归母净利润约191.51亿元 同比增长约102.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602554921","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602554921?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:55","pubTimestamp":1768229718,"startTime":"0","endTime":"0","summary":"重大事项:红星冷链(01641):香港公开发售获2309.25倍认购 每股发售价12.26港元BBSB INTL(08610):公开发售获10745.13倍认购 每股发售价0.6港元兆易创新(03986)香港公开发售获542.22倍认购 全球发售净筹约46.11亿港元恒瑞医药(01276):注射用SHR-1826被药审中心纳入突破性治疗品种名单百奥赛图-B(02315)通过基于选择权的评估框架与育","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391932.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02359","603259"],"gpt_icon":0},{"id":"2602517276","title":"【财闻联播】6个交易日涨199%!这家公司明起停牌核查!药明康德2025年净利同比预增近103%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602517276","media":"券商中国","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602517276?lang=zh_cn&edition=full","pubTime":"2026-01-12 20:57","pubTimestamp":1768222667,"startTime":"0","endTime":"0","summary":"宏观动态商务部发布关于中欧电动汽车案磋商进展的通报据中国商务部网站,为落实中欧领导人会晤共识,妥善解决欧盟对华电动汽车案,中欧双方本着相互尊重的态度,进行了多轮磋商。双方一致认为,有必要向对欧盟出口纯电动汽车的中国出口商,提供关于价格承诺的通用指导,以便中国出口商可通过更加实用、有针对性且符合世贸组织规则的方式,解决相关关注。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601123616027059.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1046422090.SGD","BK1141","603259","LU1979443071.USD","LU0708995583.HKD","LU0456842615.SGD","LU2328871848.SGD","LU1808992512.USD","LU0052750758.USD","BK0216","BK1583","02359","LU1934453819.USD","LU2488822045.USD","LU2125910500.SGD","LU1997245177.USD","LU1997245094.SGD","LU0320764599.SGD","LU2045819591.USD","BK1576","LU2242644610.SGD","LU2495084118.USD","LU1997244956.HKD","LU1969619763.USD"],"gpt_icon":0},{"id":"2602482545","title":"美股三大指数齐升 恒指50天线料有不俗支援","url":"https://stock-news.laohu8.com/highlight/detail?id=2602482545","media":"真灼财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602482545?lang=zh_cn&edition=full","pubTime":"2026-01-12 20:45","pubTimestamp":1768221940,"startTime":"0","endTime":"0","summary":"美股三大指数上周五造好,纳指表现最佳升0.95%,道指及标普500指数则分别上升0.48%及0.65%,反映中概股表现之金龙指数则跌至1.3%。A股上周五继续有表现,上综指及深成成指分别上升0.92%及1.15%,收报4,120点及14,120点,成交金额达到3.12万亿元人民币,全周计则上综指升3.8%,深成指升幅则达到4.4%。虽然恒指上周下跌,不过整体形势并非太差,现时亦续企稳50天线水准;短期只要守稳该水准,则后市仍有望延续反弹,并挑战26,800点水准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112213227a711d5a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112213227a711d5a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WXXWY","HSI","SCHYY","603259","01801","NTES","000001","03692","QQQ","SPY","HHImain","06618","HSTECH","02269","MCHmain","00241","02359","513600","09999","02833","01928","MHImain","TQQQ"],"gpt_icon":1},{"id":"2603547549","title":"当业绩创纪录新高:药明康德为股东与员工备好“双份礼包“”——有望创新高的分红与25亿元H股激励即将解锁","url":"https://stock-news.laohu8.com/highlight/detail?id=2603547549","media":"时代周报","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603547549?lang=zh_cn&edition=full","pubTime":"2026-01-12 19:33","pubTimestamp":1768217628,"startTime":"0","endTime":"0","summary":"在取得如此亮眼的经营数据同时,药明康德也已为长期支持的股东及员工准备好了两份大礼包。依据公司一贯约30%的现金分红比例测算,药明康德2025年度现金分红总额预计将突破57亿元,创下历史新高。此外,随着营收连续超越既定目标,公司2025年H股奖励信托计划也将相应解锁。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112193404a4ba8084&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112193404a4ba8084&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1046422090.SGD","02359","LU0708995583.HKD","LU2045819591.USD","LU2125910500.SGD","BK1576","BK1141","BK1583","LU2242644610.SGD","LU0052750758.USD","LU0320764599.SGD"],"gpt_icon":0},{"id":"2602168385","title":"完全拦不住,又双叒超指引了,药明康德(603259.SH/02359)2025年营收创记录至454.56亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602168385","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602168385?lang=zh_cn&edition=full","pubTime":"2026-01-12 18:35","pubTimestamp":1768214136,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,2026年1月12日晚间,药明康德发布了2025年度业绩预增公告。公司预计2025年全年营业收入约454.56亿元,创下历史新高。此前,药明康德已在三季度时第二次上调了全年经营目标。除了创记录的营业收入,药明康德的利润层面,三个口径下关键指标亦实现高于营收的增速攀升,经调整non-IFRS归母净利润、归母净利润及扣非后归母净利润,分别同比增长约41.33%、102.65%及32.56%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391732.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02359","603259"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.wuxiapptec.com.cn","stockEarnings":[{"period":"1week","weight":0.1342},{"period":"1month","weight":0.1418},{"period":"3month","weight":0.1472},{"period":"6month","weight":0.3246},{"period":"1year","weight":1.368},{"period":"ytd","weight":0.2158}],"compareEarnings":[{"period":"1week","weight":0.0052},{"period":"1month","weight":0.0336},{"period":"3month","weight":0.0362},{"period":"6month","weight":0.0959},{"period":"1year","weight":0.4225},{"period":"ytd","weight":0.0475}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"无锡药明康德新药开发股份有限公司是一家主要从事新药研发和生产服务业务的中国公司。该公司主要通过六个分部开展业务。化学业务分部主要从事提供新药研究、开发与生产服务。测试业务分部主要从事提供药品、医疗器械、体外诊断试剂服务。生物学业务分部主要从事提供药物发现及研究服务。高端治疗合同测试、研发与生产(CTDMO)业务分部主要从事为客户提供医疗产品工艺开发、生产和测试一体化服务。国内新药研发服务部分部主要从事为客户提供一体化新药研发服务。其他业务分部主要从事行政服务、销售原材料和销售废料业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.037869},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.006618},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.010471},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.015053},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.001001},{"month":6,"riseRate":0.714286,"avgChangeRate":0.076679},{"month":7,"riseRate":0.714286,"avgChangeRate":0.099103},{"month":8,"riseRate":0.571429,"avgChangeRate":0.042308},{"month":9,"riseRate":0.571429,"avgChangeRate":0.088071},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.002335},{"month":11,"riseRate":0.285714,"avgChangeRate":-0.002939},{"month":12,"riseRate":0.571429,"avgChangeRate":0.038238}],"exchange":"SEHK","name":"药明康德","nameEN":"WUXI APPTEC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明康德(02359)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明康德(02359)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明康德,02359,药明康德股票,药明康德股票老虎,药明康德股票老虎国际,药明康德行情,药明康德股票行情,药明康德股价,药明康德股市,药明康德股票价格,药明康德股票交易,药明康德股票购买,药明康德股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明康德(02359)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明康德(02359)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}